News Page

AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS)
Subscribe to the AIDSinfo At-a-Glance
e-newsletter to receive regular updates on the latest in HIV/AIDS treatment, prevention, and research.
  • "Mississippi Baby" Now Has Detectable HIV, Researchers Find
    "The child known as the 'Mississippi baby'—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable levels of HIV after more than two years of not taking antiretroviral therapy without evidence of virus, according to the pediatric HIV specialist and researchers involved in the case.

    "'Certainly, this is a disappointing turn of events for this young child, the medical staff involved in the child’s care, and the HIV/AIDS research community,' said NIAID Director Anthony S. Fauci, M.D. 'Scientifically, this development reminds us that we still have much more to learn about the intricacies of HIV infection and where the virus hides in the body. The NIH remains committed to moving forward with research on a cure for HIV infection.'"

    More information is available:
  • FDA Updates Etravirine Labeling
    "On August 20, 2014, the Intelence (etravirine) label was updated to include information regarding coadministration of etravirine with the following drugs:
    • "dolutegravir, dolutegravir/darunavir/ritonavir, dolutegravir/lopinavir/ritonavir
    • "atazanavir/ritonavir
    • "boceprevir"
    The updated labeling for etravirine is available at the FDA website.

    More information is available:
  • AIDSinfo HIV/AIDS Awareness Day Widget Now Available
    AIDSinfo is pleased to announce the release of our HIV/AIDS Awareness Day widget! Add the widget to your website or blog to display the logos for the national HIV/AIDS awareness days. The logos will link to the AIDSinfo HIV/AIDS awareness day pages. The widget also provides links to the infoSIDA HIV/AIDS awareness day pages

    Along with our HIV/AIDS awareness day widget, we also have a widget for our news feed. Add this widget to your website to display the latest HIV/AIDS treatment, prevention, and research news.

    Instructions for adding the widgets to your website can be found on the AIDSinfo widget page

    Questions about our widgets? Please send an e-mail to
  • News from CDC and NIAID
  • FDA Approves New Fixed-Dose Combination Drug, Triumeq (Abacavir Sulfate/Dolutegravir/Lamivudine), to Treat HIV Infection
    "On August 22, 2014, FDA approved a new fixed-dose combination product: TRIUMEQ, a combination of dolutegravir (integrase strand transfer inhibitor), abacavir sulfate and lamivudine (both nucleoside analogue reverse transcriptase inhibitors) for the treatment of HIV-1 infection. 
    • "TRIUMEQ alone is not recommended for use in patients with current or past history of resistance to any components of TRIUMEQ.
    • "TRIUMEQ alone is not recommended in patients with resistance-associated integrase substitutions or clinically suspected integrase strand transfer inhibitor resistance because the dose of dolutegravir in TRIUMEQ is insufficient in these subpopulations. See full prescribing information for dolutegravir. 
    "The recommended dosage regimen of TRIUMEQ in adults is one tablet once daily orally with or without food."

    The complete label for Triumeq is available at the FDA website.

    For more information, view the FDA press release.
  • AIDSinfo Glossary App Updated for iOS 7
    The free AIDSinfo HIV/AIDS Glossary apps for Apple and Android devices provide on-the-go access to definitions for more than 700 HIV/AIDS-related terms in English and Spanish. The apps also include an audio feature so users can hear the correct pronunciation of each term.
    The Glossary app for iPhone, iPad, and iPod touch is now optimized for iOS7. The updated app features an iOS7-compatible look and feel and a new icon. The upgrade also included minor bug fixes.
    Whether you are new to the Glossary app or a long-time user, download the latest, iOS7-optimized version of the app for your Apple device today. Feedback on the updated app is welcome. Please e-mail your comments to